S&P 500
5,976.83
+0.1%
+$6.46
DJI
42,527.07
+0.0%
+$7.43
NASDAQ
19,430.95
+0.2%
+$31.99
Bitcoin
105,436.00
-1.2%
-1,254.70
AAPL
$203.06
-0.1%
-$0.21
AMZN
$206.39
+0.3%
+$0.68
GOOG
$167.82
+0.1%
+$0.11
META
$680.78
+2.1%
+$13.93
MSFT
$464.44
+0.3%
+$1.47
NVDA
$140.82
-0.3%
-$0.40
TSLA
$334.29
-2.9%
-$9.98
Kane Biotech (TSXV: KNE)
CA$0.04
(-10.0%)
-CA$0.00
Price as of June 4, 2025, 10:17 a.m. ET
Kane Biotech Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Kane Biotech Company Info
Kane Biotech, Inc. is a biotechnology company, which engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. It operates through Domestic and International geographical segments. The firm's trademarks include StrixNB, DispersinB, Aledex, bluestem, silkstem, coactiv+, and Kan. The company was founded in 2001 and is headquartered in Winnipeg, Canada.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.